Biostar Pharmaceuticals (BSPM) Earning Somewhat Favorable Media Coverage, Study Finds
Media coverage about Biostar Pharmaceuticals (NASDAQ:BSPM) has trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Biostar Pharmaceuticals earned a news impact score of 0.06 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 45.906323503794 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Shares of Biostar Pharmaceuticals (BSPM) traded up $0.03 on Tuesday, hitting $1.53. The stock had a trading volume of 16,261 shares, compared to its average volume of 171,249. Biostar Pharmaceuticals has a twelve month low of $1.18 and a twelve month high of $4.30.
ILLEGAL ACTIVITY NOTICE: “Biostar Pharmaceuticals (BSPM) Earning Somewhat Favorable Media Coverage, Study Finds” was reported by Watch List News and is the sole property of of Watch List News. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://www.watchlistnews.com/biostar-pharmaceuticals-bspm-earning-somewhat-favorable-media-coverage-study-finds/1686528.html.
About Biostar Pharmaceuticals
Biostar Pharmaceuticals, Inc (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co, Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China).
Receive News & Ratings for Biostar Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biostar Pharmaceuticals Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.